Liu Yin-Qiao, Zheng Ze-Jun, Fang Wang-Kai, Li Yan-Shang, Li Chun, Yang Min, Han Dong-Chen, Zhou Jun-Hua, Xie Ying-Hua, Zhang Yu-Ying, Kang Zhuo-Ying, Xu Yi-Wei, Xie Jian-Jun
Department of Clinical Laboratory Medicine, Chaoshan Branch of State Key Laboratory for Esophageal Cancer Prevention and Treatment, the Cancer Hospital of Shantou University Medical College, Shantou 515041, China; Department of Biochemistry and Molecular Biology, Shantou University Medical College, Shantou 515041, China.
Guangdong Provincial Key Laboratory of Medical Immunology and Molecular Diagnostics, Institute of Biochemistry & Molecular Biology, Institute of Aging Research, Guangdong Medical University, Dongguan 523808, P.R. China.
Am J Hum Genet. 2025 May 1;112(5):1039-1061. doi: 10.1016/j.ajhg.2025.03.001. Epub 2025 Mar 28.
The establishment of gene expression programs that drive cell identity is governed by tightly regulated transcription factors (TFs) that engage in auto- and cross-regulation in a feedforward manner, forming core regulatory circuitries (CRCs). Here, we identify and validate an important interconnected CRC formed by three master TFs-GLI2, TP63, and RUNX1-in esophageal squamous cell carcinoma (ESCC). Furthermore, master TFs co-bind to their own and each other's super-enhancers, forming an interconnected auto-regulatory loop. Mechanistically, these master TFs occupy the majority of ESCC super-enhancers and cooperatively orchestrate the ESCC transcription program. Functionally, GLI2, a master TF, is essential for ESCC viability, migration, invasion, and the growth of xenograft tumors. Moreover, the overexpression of GLI2 is significantly associated with shorter overall survival of patients with ESCC. Downstream, this CRC apparatus coordinately regulates gene expression networks in ESCC, controlling important cancer-promoting pathways, including Hedgehog, glycolysis, and epidermal growth factor receptor signaling pathways. Together, these findings offer significant mechanistic insights into the transcriptional dysregulation in ESCC and recognize GLI2 as a potential therapeutic target and prognostic marker for ESCC. More importantly, CRC-downstream genes and signaling pathways may contain potential therapeutic targets for this malignancy.
驱动细胞身份的基因表达程序的建立受严格调控的转录因子(TFs)支配,这些转录因子以前馈方式进行自我调节和交叉调节,形成核心调节回路(CRCs)。在此,我们鉴定并验证了由三种主要转录因子——GLI2、TP63和RUNX1——在食管鳞状细胞癌(ESCC)中形成的一个重要的相互连接的CRCs。此外,主要转录因子共同结合到它们自身以及彼此的超级增强子上,形成一个相互连接的自动调节环。从机制上讲,这些主要转录因子占据了ESCC超级增强子的大部分,并协同编排ESCC转录程序。在功能上,主要转录因子GLI2对ESCC的生存能力、迁移、侵袭以及异种移植肿瘤的生长至关重要。此外,GLI2的过表达与ESCC患者较短的总生存期显著相关。在下游,这个CRCs机制协调调节ESCC中的基因表达网络,控制重要的促癌途径,包括Hedgehog、糖酵解和表皮生长因子受体信号通路。总之,这些发现为ESCC中的转录失调提供了重要的机制见解,并将GLI2识别为ESCC的潜在治疗靶点和预后标志物。更重要的是,CRCs下游的基因和信号通路可能包含针对这种恶性肿瘤的潜在治疗靶点。